[The characterization of mutant No. 68 from midecamycin producing strain S. mycarofaciens 1748].
A stable mutant No. 68 was obtained by treatment of S. mycarofaciens 1748 spores at high temperature. The electromicroscopic examination has shown that the mutant No. 68 and parent strain 1748 both have the spore chains of the spiratype. The spores of both strain are cylindrical in shape. The only difference is that the spores of the mutant No. 68 are of smooth surface, but the 1748 are of thorny. The physiological characteristics of both strains are also very similar with slight differences in utilization of few carbon sources and in cultural characters in few medium. Feeding experiment has shown that the mutant No. 68 was blocked in the formation of the macrolide lactone in the midecamycin biosynthetic pathway. This suggested that the mutant No. 68 might be a polyketide synthase genes deficient mutant. The ability of the mutant No. 68 to convert spiramycin into 4"-propionylspiramycin indicated that the mutant No. 68 contained the midecamycin 4"-propionyltransferase and could be used for microbial bioconversion of spiramycin into 4"-propionylspiramycin.
Wang
Y
Y
Institute of Medicinal Biotechnology, CAMS, Beijing.
Xiao
C
C
Gong
L
L
Liu
R
R
D007933:Leucomycins / Q000096:biosynthesis*; D009154:Mutation; D015572:Spiramycin / Q000378:metabolism; D013302:Streptomyces / Q000235:genetics / Q000302:isolation & purification* / Q000502:physiology
D007933:Leucomycins; D015572:Spiramycin; C026483:midecamycin